Association of immunologically confirmed delayed drug reaction and human herpesvirus 6 viremia in a pediatric case of drug-induced hypersensitivity syndrome

Dermatology

Volumn 222, Issue 2, 2011, Pages 140-141

  Hubiche, Thomas ^a,b   Milpied, Brigitte ^a   Cazeau, Christine ^a   Taïeb, Alain ^a   Léauté Labrèze, Christine ^a  

^a HÔPITAL PELLEGRIN   (France)

^b Dermatology and Infectious Diseases Unit   (France)

Author keywords

Drug patch testing; Drug reaction with eosinophilia and systemic symptoms; Drug induced hypersensitivity syndrome; Human herpesvirus type 6; Hypersensitivity syndrome reaction; Trimethoprim sulfamethoxazole

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CEFOTAXIME; COTRIMOXAZOLE; PREDNISONE; RIFAMPICIN;

ALKALINE PHOSPHATASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ANTIBIOTIC THERAPY; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTHENIA; CASE REPORT; CHILD; CHOLESTASIS; CLINICAL FEATURE; CORTICOSTEROID THERAPY; CYTOLYSIS; DISEASE ASSOCIATION; DRESS SYNDROME; DRUG ERUPTION; DRUG WITHDRAWAL; EPIDURITIS; FACE EDEMA; FEVER; HEPATOSPLENOMEGALY; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; HYPERTHERMIA; LETTER; LEUKOCYTOSIS; LIVER DISEASE; LOW BACK PAIN; LYMPHADENITIS; MALE; MONONUCLEOSIS; MYELITIS; PATCH TEST; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SKIN EDEMA; SKIN EXAMINATION; SKIN PRURITUS; VIREMIA;

ANTI-INFECTIVE AGENTS; CHILD, PRESCHOOL; DRUG ERUPTIONS; DRUG THERAPY, COMBINATION; HERPESVIRUS 6, HUMAN; HUMANS; HYPERSENSITIVITY, DELAYED; LOW BACK PAIN; MALE; PATCH TESTS; RIFAMPIN; ROSEOLOVIRUS INFECTIONS; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; VIREMIA;

EID: 79955698085     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000324506     Document Type: Letter

References (11)

1. Barbaud A, Reichert-Penetrat S, Tréchot P, et al: The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998; 139: 49-58. (Pubitemid 28338063)
2. Shiohara T, Inaoka M, Kano Y: Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol Int 2006; 55: 1-8.
3. Lammintausta K, Kortekangas-Savolainen O: The usefulness of skin tests to prove drug hypersensitivity. Br J Dermatol 2005; 152: 968-974. (Pubitemid 40704937)
4. Santiago F, Gonçalo M, Vieira R, Coelho S, Figueiredo A: Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS). Contact Dermatitis 2010; 62: 47-53.
5. Carroll MC, Yueng-Yue KA, Esterly NB, Drolet BA: Drug-induced hypersensitivity syndrome in pediatric patients. Pediatrics 2001; 108: 485-492.
6. Hashizume H, Takigawa M, Tokura Y: Characterization of drug-specific T cells in phenobarbital-induced eruption. J Immunol 2002; 168: 5359-5368. (Pubitemid 34496005)
7. Descamps V, Bouscarat F, Laglenne S, et al: Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol 1997; 137: 605-608. (Pubitemid 27469515)
8. Descamps V, Valance A, Edlinger C, et al: Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2001; 137: 301-304. (Pubitemid 32240782)
9. Suzuki Y, Inagi R, Aono T, et al: Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 1998; 134: 1108-1112. (Pubitemid 28432325)
10. Seishima M, Yamanaka S, Fujisawa T, et al: Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome. Br J Dermatol 2006; 155: 344-349. (Pubitemid 44050568)
11. Caserta MT, Hall CB, Schnabel K, et al: Diagnostic assays for active infection with human herpes virus 6 (HHV-6). J Clin Virol 2010; 48: 55-57.